Bile Duct Cancer

In this video, Sumera I. Ilyas, MBBS, gastroenterologist, physician-scientist and transplant hepatologist with Mayo Clinic, discusses areas of unmet need, including early diagnosis.

In this video, Sumera I. Ilyas, MBBS, gastroenterologist, physician-scientist and transplant hepatologist with Mayo Clinic, discusses challenges in diagnosing cholangiocarcinoma during the COVID-19 pandemic.

In this video, Sumera I. Ilyas, MBBS, gastroenterologist, physician-scientist and transplant hepatologist with Mayo Clinic, discusses the current landscape of targeted treatment in cholangiocarcinoma.

In this video, Sumera I. Ilyas, MBBS, gastroenterologist, physician-scientist and transplant hepatologist with Mayo Clinic, discusses understanding the tumor landscape of cholangiocarcinoma.

The FDA granted priority review to futibatinib for treatment of certain patients with cholangiocarcinoma.

Allan Tsung, MD, has been appointed chair of the department of surgery at University of Virginia School of Medicine.

The FDA granted fast track designation to TT-00420 for treatment of patients with cholangiocarcinoma who have no standard therapy options.

The FDA granted orphan drug designation to gavo-cel for treatment of cholangiocarcinoma.

The FDA approved ivosidenib tablets for adults with previously treated, locally advanced or metastatic IDH1-mutated cholangiocarcinoma.

Renuka Iyer, MD, received the Mark R. Clements Award for Vision, Innovation and Collaboration from the Cholangiocarcinoma Foundation.